Medical Devices Series B Investors & VC Firms
660 firms in this list, with a median first check of $730K. 140 of them lead rounds. Generated from verified public data and updated continuously.
Thursday Ventures Management Llc
BrandonSeed–Growth
4 people
Alpha Square Group
New YorkSeries A–Series B
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
Percipient Capital
LondonSeed–Late Stage$1.3M – $6.3M
3 people
SBCVC
TortolaSeed–Late Stage
6 people
Waterman Ventures
UtrechtSeed–Late Stage
3 people
BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
11 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
5 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
NewMargin Ventures
ShanghaiPre-Seed–Late Stage$425K – $200M
5 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Venture
ZurichPre-Seed–Series B
8 people
TRICAPITAL
Scottish BordersSeed–Growth$315K – $2.5M
2 people
Split Rock Partners
Eden PrairieSeed–Late Stage$2M – $40M
4 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
10 people
4see Ventures
Chêne-BougeriesPre-Seed–Series B$432K – $1.1M
2 people
Dementia Discovery
LondonPre-Seed–Series C
6 people
Medical Incubator Japan K.K.
TokyoSeries A–Series B
SPRINT Accelerator
MoscowPre-Seed–Growth
University Associates Venture Capital
TucsonSeed–Growth
4 people
Gore Range Capital
SouthlakeSeed–Late Stage$500K – $5M
3 people
Seventure Partners
ParisSeed–Growth
5 people
Axil Capital
TokyoSeed–Late Stage
7 people
Related lists
Series B Investors & VC Firms (4094)Series B Investors & VC Firms in United States (1625)Medical Devices Investors & VC Firms (1393)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Medical Devices Seed Investors & VC Firms (1155)Medical Devices Series A Investors & VC Firms (1145)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.













































